Maximum quantity allowed is 999
Please select the quantity
CAS RN: 56776-01-3 | Product Number: T2954
Tulobuterol Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 2-tert-Butylamino-1-(2-chlorophenyl)ethanol Hydrochloride
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 100MG |
S$85.50
|
≥40 | 4 | Contact Us |
|
* Please contact our distributors or
TCI
to order TCI products.
* The storage conditions are subject to change without notice.
| Product Number | T2954 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__2H__1__8ClNO·HCl = 264.19 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic |
| CAS RN | 56776-01-3 |
| Related CAS RN | 41570-61-0 |
| Reaxys Registry Number | 5646719 |
| PubChem Substance ID | 253662260 |
| Merck Index (14) | 9811 |
| MDL Number | MFCD00214398 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 159.0 to 164.0 °C |
Properties (reference)
| Melting Point | 160 °C |
| Solubility (soluble in) | Acetone |
| Solubility (insoluble in) | Ether |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | DN8785000 |
Transport Information:
| H.S.code* | 2922.19-000 |
Application
Tulobuterol: A β2-Adrenergic Receptor Agonist
Tulobuterol is a β2-adrenergic receptor agonist to induce relaxation of airway smooth muscle cells. The mechanism of action is explained as follows. Occupation of β2-adrenergic receptors by tulobuterol results in the activation of the adenylyl cyclase (AC), leading to an increase in intracellular cyclic AMP [A2381] and activation of protein kinase A (PKA). PKA phosphorylates Ca2+-ATPase, resulting in opening of Ca2+-activated K+ channels, decreasing intracellular Ca2+ concentration, and also decreased myosin light chain kinase (MLCK) activity. Tulobuterol transdermal patch as a controlled-release drug delivery system is used for medical purposes. (The product is for research purpose only.)
References
- Quantitative evaluation of the β2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines
- Determination of β-agonist residues in bovine urine using liquid chromatography-tandem mass spectrometry
- Pulmonary Pharmacology
- L. L. Brunton, B. A. Chabner, B. C. Knollmann, Goodman & Gilman’s The Pharmacological Basis of Therapeutics 12th edition, USA McGraw Hill Inc., 2011.
- Transdermal Tulobuterol Patch, a Long-Acting β2-Agonist (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.